re: Ann: MVP Announcement - Successful Clini... Hi bubsmark. Not over-valued, no. A high PE/r, yes- because growth is expected. Otherwise, it would be lower. I know PE/r's are usually useful to compare with other companies, and I haven't done that, so I can only go on what it is now. This from the last ANN on the submission of European regulatory authority dossier:
"MVP CEO, Mr. John Sharman said “the acceptance of our Marketing Authorisation Application for review is a
significant milestone for our company. The dossier has the potential to be “company making”, not only by an approval in Europe but by using it to apply for registration in other jurisdictions.”
_____
When a company like MVP says acceptance would be a "company maker", I believe him. Those are not words to be used lightly. If, or more like when, MVP receives acceptance, it will do well. When it achieves increasing sales from this, it will do even better.
If anyone can find out from the company how long this process will take to receive a reply from the Euro authorities, that would be terrific.
re: Ann: MVP Announcement - Successful Clini... Hi bubsmark. Not...
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
43.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.11M | |||
| Open | High | Low | Value | Volume |
| 42.5¢ | 43.0¢ | 40.5¢ | $44.56K | 107.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 24390 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.0¢ | 25904 | 3 |
View Market Depth
| Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
43.0¢ |
Change
0.000 ( 3.09 %) |
||||
| Open | High | Low | Volume | ||
| 41.5¢ | 43.0¢ | 40.5¢ | 21278 | ||
| Last updated 15.59pm 17/05/2024 ? | |||||
| MVP (ASX) Chart |